Our Firm is looking forward to this upcoming conference, as we are representing Lipitor plaintiffs in this litigation.
New York, NY (PRWEB) April 05, 2015
The federal court overseeing thousands of Lipitor lawsuits (http://www.lipitorlawsuitcenter.com/) has scheduled the multidistrict litigation’s next Case Management Conference for Thursday, April 23rd at 10:00 a.m. The calendar for the U.S. District Court, District of South Carolina indicates that the Conference will address issues pertaining to product liability claims filed on behalf of Lipitor patients who allegedly developed new-onset Type 2 diabetes due to its use. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)
“Our Firm is looking forward to this upcoming conference, as we are representing Lipitor plaintiffs in this litigation. The proceeding should provide an opportunity to obtain more information about the status of discovery, upcoming bellwether trials, and other matters impacting our clients,” Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to provide free and confidential case reviews to individuals who may have been harmed by Lipitor.
According to court documents, the federal Lipitor litigation includes more than 2,000 lawsuits, all of which have been consolidated in the District of South Carolina for the purposes of coordinated pretrial proceedings. Filings indicate that these legal actions were initiated after the U.S. Food & Drug Administration (FDA) warned in February 2012 that cholesterol-lowering statins like Lipitor might be associated with an increased risk of new-onset Type 2 diabetes. At the time, the agency required that new information be added to the labels of Lipitor and other statins regarding their potential effect on blood glucose levels. However, Lipitor lawsuit plaintiffs claim that the label modifications made by Pfizer still do not adequately warn that the drug may increase the risk for diabetes.
Court records indicate that jury selection for the first bellwether trial of a lawsuit involving Lipitor and diabetes will begin on November 4, 2015. In multidistrict litigations, bellwether trials serve as test cases, and the outcome of this proceeding may provide valuable insight into how juries could rule in similar Lipitor lawsuits.
Lipitor patients who allegedly developed Type 2 diabetes due to its use may be entitled to compensation for medical bills, lost wages, pain and suffering, and other damages related to the disorder. To learn more about filing a Lipitor lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have ben able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com